Bodhi Tree Biotechnology Inc (BDTB) EPS (Basic) (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported EPS (Basic) for 3 consecutive years, with -$0.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 11.65% year-over-year to -$0.0 in Q2 2026; TTM through Jun 2026 was -$0.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$0.01, down 21.39% from the prior year.
• EPS (Basic) was -$0.0 for Q2 2026 at Bodhi Tree Biotechnology, up from -$0.0 in the prior quarter.
• Over five years, EPS (Basic) peaked at -$0.0 in Q3 2025 and troughed at -$0.0 in Q4 2024.
• A 3-year average of -$0.0 and a median of -$0.0 in 2025 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) grew 18.26% in 2025 and retreated 11.65% in 2026, its largest moves.
• Over 3 years, EPS (Basic) stood at -$0.0 in 2024, then gained by 18.26% to -$0.0 in 2025, then jumped by 56.2% to -$0.0 in 2026.
• The last three EPS (Basic) figures came in at -$0.0 (Q2 2026), -$0.0 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.